Stock listing

Valneva Se

Selected listing: VLA · BX · CHF · CH

Valneva Se (BX Swiss: VLA), Health Technology. Latest release Oct 5, 2026: Declaration of shares and voting rights - Status as of September 30, 2026.

VLA:BXCHFCHUpdated October 3, 2026

Ticker: BX Swiss: VLA
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: BX Swiss
Currency: CHF

About Valneva Se

Valneva SE is a public company listed on the French market under the ticker VLA. Valneva focuses on developing and commercializing innovative vaccines to address unmet medical needs.

Latest news from Valneva Se

Declaration of shares and voting rights - Status as of September 30, 2026

October 5, 2026

Declaration of shares and voting rights - Status as of August 31, 2026

September 4, 2026

Déclaration d’actions et de droits de vote - Statut au 31 août 2026

September 3, 2026

Pfizer et Valneva annoncent l’acceptation pour revue par l’Agence européenne des médicaments (EMA) de la demande d’autorisation de mise sur le marché de leur candidat vaccin contre la maladie de Lyme

August 13, 2026

Valneva Half-Year 2026 Financial Report

August 12, 2026

All Valneva Se news →

Events

Replays

Valneva SE (VALN) Q2 2026 Earnings Call
Thu, Aug 13, 2026 · 09:00 AM ET
Watch
Valneva SE (VALN) Q1 2026 Earnings Call
Wed, May 13, 2026 · 09:00 AM ET
Watch
Valneva SE (VALN) Q4 2025 Earnings Call
Wed, Mar 18, 2026 · 10:00 AM ET
Watch

Research Valneva Se

Valneva Se company profile

View the public company page for Valneva Se on 6ix.

Valneva Se news

Read company news and market updates connected to Valneva Se.

Valneva Se investor events

Find investor webinars, events, and replay context for Valneva Se.